1. Immunomodulatory Activity of Cytokines in Hypertension: A Vascular Perspective.
- Author
-
Dos Passos RR, Santos CV, Priviero F, Briones AM, Tostes RC, Webb RC, and Bomfim GF
- Subjects
- Humans, Inflammation immunology, Inflammation metabolism, Inflammation physiopathology, Animals, Endothelium, Vascular physiopathology, Endothelium, Vascular immunology, Endothelium, Vascular metabolism, Hypertension immunology, Hypertension physiopathology, Hypertension metabolism, Cytokines metabolism, Cytokines immunology
- Abstract
Cytokines play a crucial role in the structure and function of blood vessels in hypertension. Hypertension damages blood vessels by mechanisms linked to shear forces, activation of the renin-angiotensin-aldosterone and sympathetic nervous systems, oxidative stress, and a proinflammatory milieu that lead to the generation of neoantigens and damage-associated molecular patterns, ultimately triggering the release of numerous cytokines. Damage-associated molecular patterns are recognized by PRRs (pattern recognition receptors) and activate inflammatory mechanisms in endothelial cells, smooth muscle cells, perivascular nerves, and perivascular adipose tissue. Activated vascular cells also release cytokines and express factors that attract macrophages, dendritic cells, and lymphocytes to the blood vessels. Activated and differentiated T cells into Th1, Th17, and Th22 in secondary lymphoid organs migrate to the vessels, releasing specific cytokines that further contribute to vascular dysfunction and remodeling. This chronic inflammation alters the profile of endothelial and smooth muscle cells, making them dysfunctional. Here, we provide an overview of how cytokines contribute to hypertension by impacting the vasculature. Furthermore, we explore clinical perspectives about the modulation of cytokines as a potential therapeutic intervention to specifically target hypertension-linked vascular dysfunction., Competing Interests: Disclosures None.
- Published
- 2024
- Full Text
- View/download PDF